Three Cycles of AC Chemotherapy Regimen Increased Oxidative Stress in Breast Cancer Patients: A Clinical Hint

Overview

Journal Caspian J Intern Med

Specialty General Medicine

Date 2017 Dec 5

PMID 29201316

Citations 7

Authors

Mostafa TaherKhani

Soleiman Mahjoub

Dariush Moslemi

Ahmad Karkhah

Affiliations

Soon will be listed here.

Abstract

Background: Recent studies have suggested the importance of oxidant/antioxidant status in initiation and progression of breast cancer. The aim of this study was to evaluate oxidative stress markers in breast cancer patients before and after 3 cycles of chemotherapy with adriamycin and cytoxan (AC). Also, in this study the effect of age and the stage of disease on oxidative stress markers were compared and evaluated.

Methods: This study included 60 women with newly diagnosed stage II-III breast cancer who underwent chemotherapy with AC as the therapy-first strategy after surgery. Serum samples were obtained before treatment and after the third chemotherapy. Then, serum total antioxidant status (TAS) and malondialdehyde (MDA) as lipid peroxidation marker were analyzed. Moreover, the effects of the subject's age and clinical disease stage were investigated.

Results: A concurrent significant increase in MDA (p<0.001) and a significant decrease in TAS (p<0.001) were also observed after 3 cycles of AC chemotherapy. In addition, some changes were found in the status of oxidative stress markers which were associated with age and clinical disease stage.

Conclusion: Our data indicated that chemotherapy with AC increase the oxidative stress in breast cancer patients. The present study indicated that higher stages of the breast cancer are associated with significant increases of oxidative stress markers.

Citing Articles

Chemotherapy on hematological and biochemical parameters in breast cancer patients.

Pullakanam T, Mannangatti M, Ramesh A, Nekkala R, Vijayalakshmi P Caspian J Intern Med. 2024; 16(1):132-140.

PMID: 39619746 PMC: 11607108. DOI: 10.22088/cjim.16.1.132.

Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin.

Demirkol B, Gul S, Cortuk M, Akanil Fener N, Yavuzsan E, Eren R Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(3):e2023036.

PMID: 37712376 PMC: 10540724. DOI: 10.36141/svdld.v40i3.13847.

Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients.

Tadesse F, Leminie A Front Oncol. 2023; 13:1103013.

PMID: 37205205 PMC: 10185890. DOI: 10.3389/fonc.2023.1103013.

Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo.

Bovilla V, Kuruburu M, Bettada V, Krishnamurthy J, Sukocheva O, Thimmulappa R Biomedicines. 2021; 9(9).

PMID: 34572304 PMC: 8471069. DOI: 10.3390/biomedicines9091119.

Pre and post chemotherapy evaluation of breast cancer patients: Biochemical approach of serum selenium and antioxidant enzymes.

Pakmanesh F, Moslemi D, Mahjoub S Caspian J Intern Med. 2021; 11(4):403-409.

PMID: 33680382 PMC: 7911771. DOI: 10.22088/cjim.11.4.403.

References

Look M, Musch E . Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy. 1994; 40(1):8-15. DOI: 10.1159/000239163. View

Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, LLeonart M . Oxidative stress and cancer: an overview. Ageing Res Rev. 2012; 12(1):376-90. DOI: 10.1016/j.arr.2012.10.004. View

Masoompour S, Lankarani K, Honarvar B, Tabatabaee S, Moghadami M, Khosravizadegan Z . Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study. PLoS One. 2016; 11(5):e0155669. PMC: 4878731. DOI: 10.1371/journal.pone.0155669. View

Mahjoub S, Masrour-Roudsari J . Role of oxidative stress in pathogenesis of metabolic syndrome. Caspian J Intern Med. 2015; 3(1):386-96. PMC: 4600138. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Conklin K . Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 2004; 3(4):294-300. DOI: 10.1177/1534735404270335. View

Buege J, Aust S . Microsomal lipid peroxidation. Methods Enzymol. 1978; 52:302-10. DOI: 10.1016/s0076-6879(78)52032-6. View

Mates J . Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol. 2000; 32(2):157-70. DOI: 10.1016/s1357-2725(99)00088-6. View

Ames B . Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science. 1983; 221(4617):1256-64. DOI: 10.1126/science.6351251. View

10.

Nowak D, Janczak M . Effect of chemotherapy on serum end-products of lipid peroxidation in patients with small cell lung cancer: association with treatment results. Respir Med. 2005; 100(1):157-66. DOI: 10.1016/j.rmed.2005.04.002. View

11.

Kasapovic J, Pejic S, Stojiljkovic V, Todorovic A, Radosevic-Jelic L, Saicic Z . Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem. 2010; 43(16-17):1287-93. DOI: 10.1016/j.clinbiochem.2010.08.009. View

12.

Shiota M, Yokomizo A . [Prostate cancer and oxidative stress]. Nihon Rinsho. 2016; 74 Suppl 3:71-4. View

13.

Gholami M, Hasanjani Roushan M, Mahjoub S, Bijani A . How is total antioxidant status in plasma of Patients with brucellosis?. Caspian J Intern Med. 2015; 3(1):363-7. PMC: 4600133. View